Proliferation and AKT Activity Biomarker Analyses after Capivasertib (AZD5363) Treatment of Patients with ER+ Invasive Breast Cancer (STAKT)

John F R Robertson, Robert E Coleman, Kwok-Leung Cheung, Abigail Evans, Chris Holcombe, Anthony Skene, Daniel Rea, Samreen Ahmed, Ali Jahan, Kieran Horgan, Petra Rauchhaus, Roberta Littleford, S Y Amy Cheung, Marie Cullberg, Elza C de Bruin, Loumpiana Koulai, Justin P O Lindemann, Martin Pass, Paul Rugman, Gaia SchiavonRahul Deb, Pauline Finlay, Andrew Foxley, Julia M W Gee

Research output: Contribution to journalArticlepeer-review

7 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Proliferation and AKT Activity Biomarker Analyses after Capivasertib (AZD5363) Treatment of Patients with ER+ Invasive Breast Cancer (STAKT)'. Together they form a unique fingerprint.

Medicine & Life Sciences